News Jul 8, 2014 CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy SAN DIEGO — July 8, 2014 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic stem-cell therapies
Read MoreCardioCell Scientific Advisory Board Member Presents at the 2014 Lugano Stem Cell Meeting
News Jun 16, 2014 CardioCell Scientific Advisory Board Member Presents at the 2014 Lugano Stem Cell Meeting LUGANO, SWITZERLAND – LUGANO STEM CELL MEETING – June 16, 2014 – CardioCell LLC, a Stemedica Cell Technologies subsidiary that creates allogeneic stem-cell therapies for
Read MoreIndonesia’s BPOM Grants IND Approval for SCI to Conduct a Phase II Clinical Trial Using Stemedica’s Mesenchymal Stem Cells to Treat Acute Myocardial Infarction
News May 27, 2014 Indonesia’s BPOM Grants IND Approval for SCI to Conduct a Phase II Clinical Trial Using Stemedica’s Mesenchymal Stem Cells to Treat Acute Myocardial Infarction SAN DIEGO — May 27, 2014 — Stemedica Cell Technologies Inc., a leading manufacturer of adult, allogeneic
Read MoreCardioCell Scientific Advisory Board Members Present at the 2014 World Congress on Acute Heart Failure
News May 14, 2014 CardioCell Scientific Advisory Board Members Present at the 2014 World Congress on Acute Heart Failure ATHENS, GREECE – WORLD CONGRESS ON ACUTE HEART FAILURE– May 14, 2014 – CardioCell announces presentations by prominent chronic heart failure (CHF) opinion leaders
Read MoreCardioCell Scientific Advisory Board Chair Joins “Novel Technologies in Stem Cell Research” Panel at the 2014 Stem Cell Summit
News Apr 21, 2014 CardioCell Scientific Advisory Board Chair Joins “Novel Technologies in Stem Cell Research” Panel at the 2014 Stem Cell Summit CAMBRIDGE, MASS. – STEM CELL SUMMIT 2014 – April 21, 2014 – CardioCell announces a presentation by noted cardiologist Dr. Stephen Epstein,
Read MoreFDA Grants IND Approval for Phase IIa Clinical Trial Using CardioCell’s itMSC Therapy to Treat Dilated Chronic Heart Failure
News Apr 2, 2014 FDA Grants IND Approval for Phase IIa Clinical Trial Using CardioCell’s itMSC Therapy to Treat Dilated Chronic Heart Failure SAN DIEGO — April 2, 2014 — CardioCell LLC has just received the FDA’s investigational new drug (IND) approval for a United States-based,
Read More